The Princeton-founded startup is building evaluation and improvement tools for enterprise AI agents that need to follow complex business rules.
Crux Labs has emerged from stealth with more than $6 million in financing co-led by Benchstrength and Misneach, with participation from Analog Ventures and Pareto Holdings.
The New York startup was founded by CEO Julie Kheyfets and CTO Krishna Kulkarni, who met at Princeton. Its product addresses a problem that becomes more apparent as AI agents move from demonstrations into real business workflows: completing a task is not the same as making the right judgment.
Turning Tacit Rules Into Tests
A customer support agent may produce a fluent response but fail to follow a company's escalation policy. A healthcare or financial services agent may appear helpful while missing an exception that an experienced professional would recognize immediately.
Crux says it captures that expert knowledge within existing workflows, translates it into evaluations and monitors agent behavior across production traffic. Its platform is designed to help teams move beyond manually inspecting only a small sample of conversations or execution traces.
The goal is continuous improvement: identify where agents diverge from domain experts' expectations, prioritize the errors and feed the findings into changes that can be deployed and measured.
Crux says it has customers among high-growth technology businesses and Fortune 500 enterprises across healthcare, finance and cybersecurity. It has not disclosed revenue, customer counts or independently verified accuracy improvements.
Reliability Becomes a Product Category
Companies increasingly need systems that test and govern AI agents after deployment, not just benchmark a model before launch. Errors can be rare, highly contextual and expensive when an agent is handling financial, medical or security decisions.
Crux sits in a growing market alongside observability, evaluation and governance vendors. Its differentiator is the claim that it can encode a company's own judgment rather than rely on generic evaluation metrics.
The company will use the new funding to expand research, engineering and enterprise deployments.
Its opportunity is considerable, but so is the challenge: a system designed to evaluate judgment must itself be tested for consistency, bias and reliability. Enterprises will ultimately measure Crux by whether it makes agents safer and more useful at production scale.
Sources: PR Newswire · SiliconANGLE